New
HealthMore in Health→
Brain PET Scans Gain Role in Alzheimer’s Drug Decisions
Key Takeaways
- Amyloid PET can confirm Alzheimer’s-related amyloid pathology before treatment.
- Lecanemab and donanemab target beta-amyloid and are intended for Alzheimer’s disease.
- Tau PET can add information about disease progression and prognosis.
DE
DT Editorial Team··via medicalxpress.com